UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform
BRUSSELS, Belgium and CAMBRIDGE, Mass. — January 9, 2025 — UCB, a global biopharmaceutical company, and XtalPi, a global leader in AI drug discovery, today announced a license agreement on…